Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
Age-Dependent RGS5 Loss in Pericytes Induces Cardiac Dysfunction and Fibrosis
New paper by Anita tamiato on ahajournals …
When the heart loses its nerve: New findings on the interaction of nerves and hearts during aging
ICR Postdoc Julian Wagner published a …
Circular RNA circPLOD2 regulates pericyte function
Simone-Franziska Glaser et al. demonstrate that the hypoxia-regulated…
NEWS: Awards & Grants
Stefanie Dimmeler receives honorary doctorate from University of Bern
At the 189th dies academicus of the esteemed University of Bern on …
Stefanie Dimmeler among Highly Cited Researchers 2023
Prof. Dr. Stefanie Dimmeler / Director of the Institute of Cardiovascular Regeneration at Goethe University …
Julian Wagner receives ESC Award
Congratulations to Julian Wagner for receiving an ESC Award in recognition of outstanding scientific in …